about
Symptom subtypes of obsessive-compulsive disorder: are they relevant for treatment?New diagnostic perspectives on obsessive-compulsive personality disorder and its links with other conditions.The rites of writing papers: steps to successful publishing for psychiatrists.Assessment and treatment of hoarding disorder.An experimental investigation of mentalization ability in borderline personality disorder.Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration.Current understanding of the relationships between obsessive-compulsive disorder and personality disturbance.Routine treatment duration for clients attending a community based anxiety disorders clinic.International prescribing practices in obsessive-compulsive disorder (OCD).Patients with deliberate self-harm seen by a consultation-liaison service.The structure and intensity of self-reported autonomic arousal symptoms across anxiety disorders and obsessive-compulsive disorder.Does emotional reasoning change during cognitive behavioural therapy for anxiety?Do patients prefer face-to-face or internet-based therapy?Psychiatrists and GPs: diagnostic decision making, personality profiles and attitudes toward depression and anxiety.Further support for five dimensions of obsessive-compulsive symptoms.Patterns of hypnotic medication use for sleep disturbance amongst hospital inpatients.Diagnostic processes in mental health: GPs and psychiatrists reading from the same book but on a different page.Use of benzodiazepines in obsessive-compulsive disorder.Specificity of the Relationships Between Dysphoria and Related Constructs in an Outpatient Sample.Striving for excellence in the practice of psychiatry.Italian prescribing patterns in obsessive-compulsive disorder.A call for prevention and early intervention in obsessive-compulsive disorder.Confirmatory Factor Analysis of the Nepean Dysphoria Scale in a Clinical Sample.Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.Safety of electroconvulsive therapy after subdural haemorrhage.The clinical characteristics of obsessive compulsive disorder associated with high levels of schizotypy.Predictors of the length of stay in a psychiatric emergency care centre.The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).The Nepean Belief Scale: preliminary reliability and validity in obsessive-compulsive disorder.The familiality of specific symptoms of obsessive-compulsive disorder.The opportunity to make wise choices in our quest for excellence in the practice of psychiatry.Functions of compulsions in obsessive-compulsive disorder.DSM-5 bids farewell to hypochondriasis and welcomes somatic symptom disorder and illness anxiety disorder.Multiple cerebral infarcts following septic shock.A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorderDelusions and reasoning: A study involving cognitive behavioural therapyTreatments used for obsessive-compulsive disorder-An international perspectiveEarly intervention for obsessive compulsive disorder: An expert consensus statementChronic baclofen abuse and withdrawal delirium
P50
Q37214734-BBCBAFFB-7033-412B-B9C1-E79B93CCFC7AQ38164483-90290D06-3665-411D-86F1-2E0AEB766562Q38282062-1E22D0D2-604D-48EB-94A4-1D67DC4DE3AAQ38505293-70521189-F391-440F-9F68-FBFB0CC7256EQ38546812-192D257A-5EB2-4613-BD4D-5347AA232F7AQ38824774-FAA93BF7-75D9-4A9F-9958-57F53C2D2818Q38984198-BE066337-970B-4201-9A8F-E78ABFD88E6FQ39427290-70159F12-E070-4E4E-8102-07921180C54EQ39704050-5D879441-0A1F-4E9C-BFE6-678A949AF906Q39756927-F752FCD2-1707-49ED-9DBB-CE075411C0CEQ39839583-15D0967B-E474-4F73-92EE-2BEE1956D287Q40143489-984F320D-B918-4AD8-A6D0-31923BDD4BC3Q43707808-A1128037-43E8-4A16-9A8E-323ACCC86B21Q44233420-CCDEC26C-2FA3-4D08-929E-91072FD16140Q44683535-3FEF5A0F-77CD-46BE-81D2-9BFFBF12D144Q45876717-9358BFDC-F874-4EDA-8BE9-87ADFF29F0BAQ46379948-9FE539AC-131D-4E77-8360-ED0B81BFEC40Q47637512-2C42596B-F600-4280-A4B0-63F32A8D0023Q47753939-A7E17B1B-1C5F-4301-99F8-4AD5AC98B588Q47800692-4091538A-F7C3-468A-BF1A-33BC0F28110CQ47887750-24A34518-0839-45B1-B11A-61655B468257Q47916766-1383A5BC-E89D-492F-9C7F-5AE6D13DAA7DQ48101148-77BAA211-8FF5-4790-8463-5D35D2A23BF4Q48169010-170075C9-69FC-4D71-9A57-874DCFAC79F0Q48295510-F7BB840E-63AA-42FF-BBE0-09C2649734BEQ48311962-3B533D43-2D9F-4D72-AD70-B9D6D9111B5AQ48431424-B0078B07-9E10-4238-8962-5F7E2D68E488Q48910067-B64EE4E1-99E8-4BCF-879F-C5A238C71F7EQ50103943-4C255968-D032-4FF5-A790-7F1CF26E9D9AQ50199988-17128826-8CCD-4808-8247-F662546DE81EQ50203000-64F40407-0B67-4183-BD89-2538266DF474Q50220323-63CC2E0F-09BE-416B-AD2F-D3CFF19CF8A7Q50632260-79149E49-110D-4FD6-9587-004D50560DE5Q50657945-2417B4FA-80D0-40CE-B036-FF1953BFE5B0Q53671689-8833FC29-2674-4AA1-9DC2-9528384F8231Q58542496-9C9241A8-F043-4370-93AB-135A6F149A67Q60047921-62973821-5F90-4A3B-B0C7-BD3AFDF078F9Q60641765-EC8E3B8D-2638-4598-91AE-E9C50A14813AQ63684018-823ED995-3941-4954-A62F-FD151C45C287Q82357901-91A81621-4C99-4804-9389-B670B56C9EE1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
V Brakoulias
@ast
V Brakoulias
@en
V Brakoulias
@es
V Brakoulias
@nl
type
label
V Brakoulias
@ast
V Brakoulias
@en
V Brakoulias
@es
V Brakoulias
@nl
altLabel
Vlasios Brakoulias
@en
prefLabel
V Brakoulias
@ast
V Brakoulias
@en
V Brakoulias
@es
V Brakoulias
@nl
P106
P1153
14519139900
P31
P496
0000-0002-4188-4370